Proceedings of the Japan Academy, Series B
Online ISSN : 1349-2896
Print ISSN : 0386-2208
ISSN-L : 0386-2208
Reviews
Cupid and Psyche system for the diagnosis and treatment of advanced cancer
Akira SUGIYAMATakeshi KAWAMURAToshiya TANAKAHirofumi DOITakefumi YAMASHITAKeiko SHINODAHideaki FUJITANIKenzo YAMATSUGUYohei SHIMIZUToshifumi TATSUMIKazuki TAKAHASHIMotomu KANAIEiichi MIZOHATATatsuya KAWATOTakefumi DOITsuyoshi INOUETatsuhiko KODAMA
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2019 Volume 95 Issue 10 Pages 602-611

Details
Abstract

In advanced cancer patients, malignant cells invade and disseminate within normal cells and develop resistance to therapy with additional genetic mutations, which makes radical cure very difficult. Precision medicine against advanced cancer is hampered by the lack of systems aimed at multiple target molecules within multiple loci. Here, we report the development of a versatile diagnostic and therapeutic system for advanced cancer, named the Cupid and Psyche system. Based on the strong non-covalent interaction of streptavidin and biotin, a low immunogenic mutated streptavidin, Cupid, and a modified artificial biotin, Psyche, have been designed. Cupid can be fused with various single-chain variable fragment antibodies and forms tetramer to recognize cancer cells precisely. Psyche can be conjugated to a wide range of diagnostic and therapeutic agents against malignant cells. The Cupid and Psyche system can be used in pre-targeting therapy as well as photo-immunotherapy effectively in animal models supporting the concept of a system for precision medicine for multiple targets within multiple loci.

Content from these authors
© 2019 The Japan Academy
Previous article Next article
feedback
Top